financetom
Business
financetom
/
Business
/
MarketAxess Average Daily Volume Rises in November vs Year Ago
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MarketAxess Average Daily Volume Rises in November vs Year Ago
Dec 4, 2024 6:12 AM

08:37 AM EST, 12/04/2024 (MT Newswires) -- MarketAxess Holdings ( MKTX ) said Wednesday its total average daily volume came in at $44.95 billion in November, up 56% from a year earlier but down 3% compared to October.

Total rates ADV was $30.7 billion in November, up 112% from a year ago, but down 2% compared to October, the company said.

High-grade credit ADV was $6.53 billion in November, compared with $6.52 billion a year earlier, while high-yield credit ADV was $1.31 billion last month, compared to $1.91 billion a year ago, the company said.

MarketAxess ( MKTX ) shares fell more than 3% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tyra Biosciences' TYRA-300 Gets US FDA Clearance for Phase 2 Trial in Non-Muscle Invasive Bladder Cancer
Tyra Biosciences' TYRA-300 Gets US FDA Clearance for Phase 2 Trial in Non-Muscle Invasive Bladder Cancer
Jan 10, 2025
10:49 AM EST, 01/10/2025 (MT Newswires) -- Tyra Biosciences ( TYRA ) said Friday it obtained investigational new drug clearance from the US Food and Drug Administration for TYRA-300, moving to a phase 2 trial of the potential drug for non-muscle invasive bladder cancer. The phase 2 SURF302 trial targets to enroll up to 90 participants at several sites mainly...
Dyne Therapeutics' Muscle Dystrophy Treatment Demonstrates DMPK Reduction, Splicing Correction; Shares Fall
Dyne Therapeutics' Muscle Dystrophy Treatment Demonstrates DMPK Reduction, Splicing Correction; Shares Fall
Jan 10, 2025
10:49 AM EST, 01/10/2025 (MT Newswires) -- Dyne Therapeutics ( DYN ) said Friday that new clinical data from its ongoing phase 1/2 trial of DYNE-101 in people with myotonic dystrophy type 1 demonstrated a compelling impact on key disease biomarkers. This included the knockdown of dystrophin myotonic protein kinase, or DMPK, and splicing correction at the 6.8 mg/kg Q8W...
China's Shimao Group receives liquidation petition
China's Shimao Group receives liquidation petition
Jan 10, 2025
(Reuters) - China's Shimao Group ( SIOPF ) said on Friday CPYM Link Investment Limited had filed a liquidation petition against the company in the Hong Kong high court regarding a 258 million yuan ($35.19 million) cross-border loan guarantee provided by the property developer. The court has set the first hearing for the petition on March 19, 2025. This is...
Factbox-New U.S. sanctions against Russian energy interests
Factbox-New U.S. sanctions against Russian energy interests
Jan 10, 2025
(Reuters) - The U.S. Treasury on Friday announced sweeping new sanctions against the Russian energy sector, including oil majors Gazprom Neft and Surgutneftegaz, to try to hinder Moscow in its war with Ukraine. Britain also joined the sanctions against those two companies, the U.S. Treasury said. The sanctions also target more than 180 vessels and dozens of oil traders, oilfield...
Copyright 2023-2026 - www.financetom.com All Rights Reserved